Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 434 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Cannabinoids Clear all

Conditions: Epilepsy, Lennox-Gastaut Syndrome
Interventions: GWP42003-P 20 mg/kg/day Dose, Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 2 Years to 55 Years
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 17
States / cities: Tampa, Florida • Atlanta, Georgia • Chicago, Illinois + 14 more

Conditions: Cannabis Use, Drug Abuse
Interventions: Cannabis Cigarette; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Infantile Spasms
Interventions: GWP42003-P; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 1 Month to 24 Months
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Little Rock, Arkansas • Winston-Salem, North Carolina • Columbus, Ohio + 3 more

Conditions: Alcohol Use Disorder
Interventions: 200mg Cannabidiol oral solution, 30mg Cannabidiol oral solution, Placebo; Dietary Supplement
Lead sponsor: Colorado State University; Other
Eligibility: 21 Years to 60 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Developmental Delay
Interventions: Play and Learn Strategies (PALS) Program; Behavioral
Lead sponsor: IDeA States Pediatric Clinical Trials Network; Network
Eligibility: Up to 7 Days
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Albuquerque, New Mexico • Sioux Falls, South Dakota • Burlington, Vermont

Conditions: Knee Osteoarthritis
Interventions: Blinded study medication; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 45 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Interaction
Interventions: Cannabidiol in the form of hemp, Clopidogrel; Drug
Lead sponsor: Washington State University; Other
Eligibility: 21 Years to 64 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Cannabis Use Disorder
Interventions: Dronabinol, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 45 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Generalized Anxiety Disorder (GAD), Anxiety Disorders
Interventions: Low-Dose Cannabidiol, Placebo Matched to Moderate-Dose Cannabidiol, Moderate-Dose Cannabidiol, Placebo Matched to Low-Dose Cannabidiol; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Back Pain, Low
Interventions: Cannabidiol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: THC, Alpha-pinene
Interventions: Placebo, THC, Alpha-Pinene; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cannabis Use, Tobacco Use, Electronic Cigarette Use
Interventions: THC High Dose, THC Low Dose, THC 0mg, E-Cigarette Full Nicotine, E-Cigarette Placebo Nicotine; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cannabis, Dependence, Cannabis Abuse, Pharmacokinetics, fMRI
Interventions: Sativex(Registered Trademark), THC; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bipolar Affective Disorder, Currently in Remission, Bipolar Disorder I, Bipolar Disorder II
Interventions: Wim Hof method; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sleep, Sleep Disturbance, Sleep Disorder
Interventions: Rest Study Product Usage; Dietary Supplement
Lead sponsor: Radicle Science; Industry
Eligibility: 21 Years to 105 Years
Enrollment: 2,679 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Del Mar, California

Conditions: Tolerance, Adolescent Behavior, THC
Interventions: Dextrose, Dronabinol; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 40 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Schizophrenia, Mental Disorders, Psychotic Disorders
Interventions: THC and Iomazenil, Placebo (control); Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Influenza, COVID-19, Common Cold
Interventions: Immune Support Supplement; Dietary Supplement
Lead sponsor: Center For Interventional Pain and Spine; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Bryn Mawr, Pennsylvania

Conditions: Cannabis Use Disorder
Interventions: Cannabidiol, Placebo; Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Marijuana Smoking
Interventions: Dronabinol 120mg/day, Placebo, Dronabinol 240mg/day; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Migraine, Cannabis, THC, CBD
Interventions: THC ~5%, CBD ~12%, THC ~5% and CBD ~12%, Sham Cannabis; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 65 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Epilepsy
Interventions: Cannabidiol (Epidiolex); Drug
Lead sponsor: Augusta University; Other
Eligibility: 1 Year to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Healthy
Interventions: [(11)C] MePPEP; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Epilepsy, Lennox Gastaut Syndrome
Interventions: GWP42003-P, Placebo control; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 2 Years to 55 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 20
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 16 more

Search by objective public record fields.

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis

Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

Cannabidiol Effects on Blood Alcohol Level and Intoxication

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure

Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis

Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel

Sex Differences in Neurobehavioral Response to THC

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

Behavioral Pharmacology of THC and Alpha-pinene

Effect of Cannabis on E-Cigarette Use Behavior

Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation

Effect of Behavioral Intervention on Cannabinoid Receptors in BAD

Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes

Age-Related Effects of THC

Effects of Delta-9-THC and Iomazenil in Healthy Humans

Commercially Available Cannabis Products for Immune Support

Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder

Effects of Dronabinol (Oral THC) on Cannabis Use

Efficacy of Inhaled Cannabis for Acute Migraine Treatment

Epidiolex and Drug Resistant Epilepsy in Children

Imaging of Cannabinoid Receptors Using New Radioactive Tracer

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults